William E. Rote - May 11, 2021 Form 4 Insider Report for Travere Therapeutics, Inc. (TVTX)

Role
Senior Vice President, R&D
Signature
/s/ Elizabeth E. Reed, Attorney-in-Fact
Stock symbol
TVTX
Transactions as of
May 11, 2021
Transactions value $
-$60,312
Form type
4
Date filed
5/13/2021, 04:13 PM
Next filing
Aug 17, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TVTX Common Stock Sale -$29.9K -1.56K -4.49% $19.14 33.3K May 11, 2021 Direct F1
transaction TVTX Common Stock Sale -$30.4K -1.56K -4.7% $19.46 31.7K May 12, 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported were made pursuant to a written plan meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended, and includes the sale of shares to cover the tax obligation that occurred upon the vesting of restricted stock units.